SEC Form 4 · accession 0001127602-18-020614
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Kuntz
Officer — SVP & Chief Medical & Science
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 4:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Jun 8, 2018 | S | 11,500 | $87.13 | D | 105,923 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price is a weighted average price. These shares were sold in multiple transactions in prices ranging from $87.09 to $87.155, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4.
- F2This balance increased by 316 shares due to exempt transactions such as dividend reinvestment.